Secondary
Ascendis Pharma
Ascendis Pharma is a biopharmaceutical company applying its TransCon technology to develop a pipeline of sustained release prodrug therapies with best-in-class profiles to address significant unmet medical needs in rare diseases.
Symbol
ASND
Last Closing Price
$59.00
Effective Date
February 22, 2018
Underwriters
J.P. Morgan, BofA Merrill Lynch, Credit Suisse Securities
To view the prospectus for Ascendis Pharma, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277